The utilization of Blaptica dubia cockroaches as an in vivo model to test antibiotic efficacy.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 12 2021
Historique:
received: 13 07 2021
accepted: 03 12 2021
entrez: 15 12 2021
pubmed: 16 12 2021
medline: 28 1 2022
Statut: epublish

Résumé

Insects are now well recognized as biologically relevant alternative hosts for dozens of mammalian pathogens and they are routinely used in microbial pathogenesis studies. Unfortunately, these models have yet to be incorporated into the drug development pipeline. The purpose of this work was to begin to evaluate the utility of orange spotted (Blaptica dubia) cockroaches in early antibiotic characterization. To determine whether these model hosts could exhibit mortality when infected with bacteria that are pathogenic to humans, we subjected B. dubia roaches to a range of infectious doses of Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, and Acinetobacter baumannii to identify the medial lethal dose. These results showed that lethal disease did not develop following infection of high doses of S. aureus, and A. baumannii. However, cockroaches infected with E. coli and K. pneumoniae succumbed to infection (LD50s of 5.82 × 10

Identifiants

pubmed: 34907348
doi: 10.1038/s41598-021-03486-3
pii: 10.1038/s41598-021-03486-3
pmc: PMC8671488
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

24004

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM103434
Pays : United States
Organisme : NHLBI NIH HHS
ID : R15 HL147135
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):49-55
pubmed: 7587050
Antimicrob Agents Chemother. 2001 Mar;45(3):845-51
pubmed: 11181370
In Vivo. 2006 Jan-Feb;20(1):91-6
pubmed: 16433034
Int J Antimicrob Agents. 2020 Dec;56(6):106200
pubmed: 33075514
Clin Infect Dis. 1998 Jul;27(1):10-22
pubmed: 9675443
Infect Immun. 2008 Mar;76(3):1267-75
pubmed: 18195031
Antibiotics (Basel). 2019 Apr 24;8(2):
pubmed: 31022923
Virulence. 2019 Dec;10(1):527-541
pubmed: 31142220
Appl Environ Microbiol. 2010 Jan;76(1):310-7
pubmed: 19897755
Nat Protoc. 2008;3(2):163-75
pubmed: 18274517
Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S503-11
pubmed: 3025997
Infect Immun. 2012 Aug;80(8):2780-90
pubmed: 22645286
J Med Microbiol. 2011 May;60(Pt 5):661-669
pubmed: 21233296
J Pharm Pharmacol. 2003 Apr;55(4):559-66
pubmed: 12803779
Virulence. 2013 Jul 1;4(5):419-28
pubmed: 23652836
PLoS One. 2013 May 30;8(5):e64638
pubmed: 23737991
Front Cell Infect Microbiol. 2013 Dec 06;3:93
pubmed: 24367766
Microbiology (Reading). 2009 May;155(Pt 5):1516-1522
pubmed: 19383703
Yao Xue Xue Bao. 1990;25(6):406-11
pubmed: 2284964
J Antimicrob Chemother. 1980 Sep;6 Suppl A:25-30
pubmed: 6252166
J Vis Exp. 2013 Nov 22;(81):e50964
pubmed: 24299965
Antimicrob Agents Chemother. 2020 Dec 16;65(1):
pubmed: 33106262
Virulence. 2016 Apr 2;7(3):214-29
pubmed: 26730990
Virulence. 2021 Dec;12(1):2104-2121
pubmed: 34374318
Int J Antimicrob Agents. 2015 Nov;46(5):538-45
pubmed: 26364845
Int J Antimicrob Agents. 2016 Oct;48(4):367-72
pubmed: 27451856
J Antibiot (Tokyo). 1976 May;29(5):492-500
pubmed: 956036
Scand J Plast Reconstr Surg Hand Surg. 1995 Sep;29(3):259-62
pubmed: 8539570
Antimicrob Agents Chemother. 2009 Jun;53(6):2605-9
pubmed: 19332683
BMC Microbiol. 2012 Jun 22;12:117
pubmed: 22892068
Proc W Va Acad Sci. 2017;89(3):34-47
pubmed: 29578544
Am J Hosp Pharm. 1987 Jan;44(1):131-7
pubmed: 3826085
PLoS Comput Biol. 2020 Aug 3;16(8):e1008037
pubmed: 32745111
Antimicrob Agents Chemother. 1990 Jun;34(6):1160-4
pubmed: 2393276
Infect Immun. 2013 Oct;81(10):3552-65
pubmed: 23836821
J Microbiol Immunol Infect. 2017 Feb;50(1):55-61
pubmed: 25682237
Clin Pharmacol Ther. 1978 Jul;24(1):108-16
pubmed: 657712
J Vis Exp. 2012 Dec 11;(70):e4392
pubmed: 23271509
Clin Infect Dis. 2009 Dec 1;49(11):1749-55
pubmed: 19857164
FEMS Immunol Med Microbiol. 2002 Oct 11;34(2):153-7
pubmed: 12381467
Antimicrob Agents Chemother. 2011 Jun;55(6):2655-61
pubmed: 21422204
Infect Immun. 2003 May;71(5):2404-13
pubmed: 12704110
Infect Immun. 2005 Jul;73(7):3842-50
pubmed: 15972469
Jpn J Antibiot. 1995 May;48(5):610-20
pubmed: 7637195
J Antimicrob Chemother. 1991 May;27 Suppl C:29-40
pubmed: 1830302

Auteurs

Elliot Collins (E)

Department of Biological Sciences, West Liberty University, West Liberty, WV, USA.

Caleb Martin (C)

Department of Biological Sciences, West Liberty University, West Liberty, WV, USA.

Tyler Blomquist (T)

Department of Biological Sciences, West Liberty University, West Liberty, WV, USA.

Katherine Phillips (K)

Department of Biological Sciences, West Liberty University, West Liberty, WV, USA.

Stuart Cantlay (S)

Department of Biological Sciences, West Liberty University, West Liberty, WV, USA.

Nathan Fisher (N)

Noblis ESI, Chantilly, VA, USA.

Joseph Horzempa (J)

Department of Biological Sciences, West Liberty University, West Liberty, WV, USA. joseph.horzempa@westliberty.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH